In the article,
“Drugs Past Their Expiration Date”, authors hypothesized that expired
medication can be effective in providing that drug’s original therapeutic
effect. The article referenced a study
about the effectiveness of Asthmo-Kranit, a medication marketed from
1952-1989. This medication was a mixture
including Theophylline, Aminopyrine, Phenobarbital, Ephedrine, Atropine, and
Benzylethyldimethoxyisochinoline.
According to this study a patient ingested 22 tables of Asthmo-Kranit
that was 35 years old as a suicide attempt.
According to the toxicology testing of these stored and old tablets,
researchers found an 80-83% of effective drug.
This 80-83% active drug was enough to cause grade 1 Theophylline
toxicity and observed signs and symptoms of Theophylline overdose. The article reported results of other
research that varied from 90% original potency of 28-40 year old sealed
medications to less stable liquid solutions containing effective dose after 50
years after expiration dates.
The authors
describe how storage can influence drug potency and report that an increase in
heat and humidity would increase the rate at which the drug lost its
effectiveness. The authors use a study in where a sodium powder stored at 40
degrees Celsius and at 75 % relative humidity was stable after 1.5-9 years. The
authors also describe how cloudy, precipitant, or discolored solutions are not
to be consumed.
These results
can impact healthcare positively in the sense that medications can last longer
and can be used in a wider period of time, thus decreasing the amount of
refills and cost of new prescription.
This may help people continue to take their medications instead of
stopping and causing their diseases to get worse due to the lack of the
medication itself. The biomedical ethic
principle of justice can be applied here because many patients without
insurance or access to continued care can benefit from using the medications
they already have. This could also be
positive in the sense that fewer medications can be wasted and put to
therapeutic use in clinical settings.
Less wasted medication can also mean less toxic chemicals thrown into
the environment and making less people sick from exposure. A negative impact can also be assumed. If drugs last longer, pharmaceutical
companies can use this fact to increase cost of medications and further
decrease access to medication to patient’s who cannot afford them, therefore
causing more harm and violating the principle of non-maleficence.
References
Drugs Past Their Expiration
Date | The Medical Letter, Inc. (n.d.). Retrieved from
https://secure.medicalletter.org/w1483b
This is definitely something that needs to be examined more closely. On one hand, I understand the reason why drugs like antibiotics have a shelf life. You don’t really want people having a surplus of drugs around and taking the wrong medication when it is not necessary. On the other hand, with the increasing cost in all areas of healthcare, you would think that it would be an area where money could be saved. I think the FDA’s relationship with the pharmaceutical industry could prevent this and a major problem like you mentioned. The FDA’s funding used to come through the US treasury. People paid their taxes and the FDA got appropriations from the budget. Since 1992, the FDA’s funding has been able to come directly from industry. To me it has created an inappropriate relationship, placing the FDA in the pockets of big pharma. Are drugs getting approved that should not? Or are they being fast tracked? I agree that if medications are allowed to stay around for longer periods of time, price hikes would likely result. The overlap of politics and medicine is always an interesting topic. It seems like there is a lot that needs to change.
ReplyDelete